Cacti Asset Management LLC Organon & Co. Transaction History

Cacti Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 01, 2024	SELL	$17.45 - $21.96 $6,142 - $7,729	-352 Reduced 8.12%	3,985 $82,000
Q1 2024 Jun 03, 2024	SELL	$13.78 - $18.8 $508,840 - $694,208	-36,926 Reduced 89.49%	4,337 $81,000
Q1 2024 Apr 01, 2024	SELL	$13.78 - $18.8 $128,016 - $174,652	-9,290 Reduced 18.38%	41,263 $775,000
Q4 2023 Jan 02, 2024	SELL	$10.95 - $17.32 $121,205 - $191,715	-11,069 Reduced 17.96%	50,553 $728,000
Q1 2023 Apr 03, 2023	SELL	$21.42 - $32.08 $664 - $994	-31 Reduced 0.05%	61,622 $1.45 Million
Q4 2022 Jan 03, 2023	SELL	$23.31 - $28.61 $11,421 - $14,018	-490 Reduced 0.79%	61,653 $1.72 Million
Q3 2022 Oct 03, 2022	BUY	$23.4 - $34.25 $1.45 Million - $2.13 Million	62,143 New	62,143 $1.45 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.06B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cacti Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Cacti Asset Management LLC with notifications on news.